These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35665803)

  • 81. MicroRNA-centric measurement improves functional enrichment analysis of co-expressed and differentially expressed microRNA clusters.
    Lee SY; Sohn KA; Kim JH
    BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S17. PubMed ID: 23281707
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer.
    Liu SQ; Gao ZJ; Wu J; Zheng HM; Li B; Sun S; Meng XY; Wu Q
    J Hematol Oncol; 2022 Mar; 15(1):19. PubMed ID: 35241110
    [TBL] [Abstract][Full Text] [Related]  

  • 84. ATAXIC: An Algorithm to Quantify Transcriptomic Perturbation Heterogeneity in Single Cancer Cells.
    Liu Q; Lu Q; Wang X
    J Oncol; 2022; 2022():4106736. PubMed ID: 36090907
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.
    Li H; Qu L; Yang Y; Zhang H; Li X; Zhang X
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1592-1609.e9. PubMed ID: 35219893
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Decomposition of RNA methylome reveals co-methylation patterns induced by latent enzymatic regulators of the epitranscriptome.
    Liu L; Zhang SW; Zhang YC; Liu H; Zhang L; Chen R; Huang Y; Meng J
    Mol Biosyst; 2015 Jan; 11(1):262-74. PubMed ID: 25370990
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.
    Lu X; Zhang K; Van Sant C; Coon J; Semizarov D
    BMC Med Genomics; 2010 Jun; 3():23. PubMed ID: 20569491
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy.
    Pfefferle AD; Spike BT; Wahl GM; Perou CM
    Breast Cancer Res Treat; 2015 Jan; 149(2):425-37. PubMed ID: 25575446
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
    Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
    Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
    Jairath NK; Farha MW; Srinivasan S; Jairath R; Green MD; Dess RT; Jackson WC; Weiner AB; Schaeffer EM; Zhao SG; Feng FY; El Naqa I; Spratt DE
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32599760
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer.
    Guo L; Zhao Y; Yang S; Cai M; Wu Q; Chen F
    Mol Biol Rep; 2013 Mar; 40(3):2175-86. PubMed ID: 23196705
    [TBL] [Abstract][Full Text] [Related]  

  • 94. BREM-SC: a bayesian random effects mixture model for joint clustering single cell multi-omics data.
    Wang X; Sun Z; Zhang Y; Xu Z; Xin H; Huang H; Duerr RH; Chen K; Ding Y; Chen W
    Nucleic Acids Res; 2020 Jun; 48(11):5814-5824. PubMed ID: 32379315
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
    Kang T; Yau C; Wong CK; Sanborn JZ; Newton Y; Vaske C; Benz SC; Krings G; Camarda R; Henry JE; Stuart J; Powell M; Benz CC
    Breast Cancer Res; 2020 Jul; 22(1):81. PubMed ID: 32736587
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of global gene expression profiles of microdissected human foetal Leydig cells with their normal and hyperplastic adult equivalents.
    Lottrup G; Belling K; Leffers H; Nielsen JE; Dalgaard MD; Juul A; Skakkebæk NE; Brunak S; Rajpert-De Meyts E
    Mol Hum Reprod; 2017 May; 23(5):339-354. PubMed ID: 28333300
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.
    Peng S; Hebert LL; Eschbacher JM; Kim S
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291647
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
    Poole W; Leinonen K; Shmulevich I; Knijnenburg TA; Bernard B
    PLoS Comput Biol; 2017 Feb; 13(2):e1005347. PubMed ID: 28170390
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
    Ding S; Chen X; Shen K
    Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis.
    Kang Z; Wang J; Huang W; Liu J; Yan W
    Front Cell Dev Biol; 2022; 10():874429. PubMed ID: 35646893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.